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The S region of the H-2 complex controls the serum levels of two proteins, Ss and 
Sip, which are closely related antigenically (1-4).  Several observations suggest  that 
the Ss protein may be part of the complement system and homologous to C4. F(ab')2 
fragments of antibody to Ss inhibit the hemolytic activity of mouse serum (5) and Ss 
antigenic determinants are incorporated into immune complexes after complement 
activation  (6).  Furthermore, Ss shares some physicochemical properties with C4 of 
other species (7, 8) and some antisera to human C4 cross-react with Ss (9). As for the 
Sip protein, its function is unknown. 
The present report demonstrates that Ss and Sip can be distinguished functionally 
by (a)  their role in the hemolytic complement system, (b) their susceptibility to Cls 
enzymatic activity, and (c) their affinity for the C4-binding protein (C4-bp) 1 (10,  11). 
In addition, new information regarding structural characteristics of these two proteins 
is presented. 
Materials and Methods 
Reagents.  Agarose was obtained from Behring Diagnostics, American Hoechst Corp., Som- 
merville, N. J.; N,N'-methylene-bisacrylamide, N,N,N',N'-tetramethyletheylenediamine, am- 
monium persulphate, and sodium dodecyl sulfate  (SDS), were obtained from Bio-Rad Labo- 
ratories,  Richmond, Calif.;  diisopropylfluorophosphate (DFP)  from Calbiochem, San Diego, 
Calif.;  bovine serum albumin (BSA) from Miles Laboratories Inc., Miles Research Products, 
Elkhart, Ind.; Staphylococcus aureus, Cowan I, (IgGsorb), New England Enzyme Center, Boston, 
Mass.; Nonidet P°40 (NP-40), Shell Chemicals Co., London, England; ovalbumin, fl-galacto- 
sidase (from Escherichia colt), eatalase  (from beef liver), myoglobin (from horse heart), alcohol 
dehydrogenase (from yeast),  and phosphorilase  A  (from rabbit muscle) were obtained from 
Sigma Chemical Corp., St. Louis, Mo.; ferritin albumin, and Sephadex G-200 from Pharmacia 
Fine Chemicals,  Div. of Pharmacia, Inc.,  Piscataway,  N. J.;  DEAE-eellulose  (DE-52)  from 
Whatman Chemicals,  Div. W  & R  Balston,  Maidstone, Kent, England. Pevikon  G-870 was 
obtained from Stockholm Superfosfat Fabriks A.-B., Stockholm, Sweden; ammonium sulphate 
was obtained from Schwarz/Mann Div., Becton Dickinson & Co., Orangeburg, N. Y. 
Buffers.  Phosphate-buffered saline  (Dulbecco's  PBS), Grand Island  Biological Co., Grand 
Island, N. Y. PBS-EDTA:  PBS containing 2 mM Na3H EDTA, pH 7.55. Barbital buffer, pH 
* Supported by grants AI-08499,  AI-13224,  AI-13809,  and CA-16247 from the National Institutes of 
Health. 
l Abbreviations used in this paper:  BSA, bovine serum albumin; CIE, crossed immunoelectrophoresis; C4- 
bp, C4-binding protein; DFP, diisopropylfluorophosphate; DGVB  ++, GVB mixed with an equal volume of 
5% dextrose in water containing 0.00015  M  MgCl~  and 0.00015  M  CaCI~;  DO(], deoxycollate; GVB  ++, 
VBS containing 1% gelatin, 0.005  M  MgCI2,  and 0.00015  M  CaCI2;  NET, sodium chloride-EDTA-Tris 
buffer; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; RIE, rocket immunoe- 
lectrophoresis; SDS, sodium dodecyl sulfate; VBS, isotonic veronal-buffered saline. 
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8.6, containing 0.023 M sodium barbital, 0.037 M barbituric acid, and 0.002 M NasH EDTA. 
Isotonic veronai-buffered saline (VBS-), pH 7.4, containing 0.025 M barbital, NaCI added to 
achieve a conductivity of 7.4 mS at 0°C, and 0.002  M  NaaH EDTA, (VBS-EDTA). GVB++: 
VBS containing  0.1% gelatin, 0.005 M MgCI2, and 0.00015 M CaCI2. DGVB++: GVB  ++ mixed 
with an equal volume of 5%  dextrose in water containing 0.001  M  MgCI2  and 0.00015  M 
CaCI2.  Sodium chloride-EDTA-Tris buffer (NET), containing 0.15  M  NaCI, 0.005  M  Tris, 
0.002  M  NasH  EDTA, and 0.02%  wt/vol sodium azide,  pH  7.4. NET-0.5%  NP-40:  NET 
containing 0.5% NP-40 vol/vol. NET-0.05% NP-40:  NET containing 0.05%  vol/vol NP-40. 
Deoxyeollate buffer (DOC buffer): containing 0.02  M  Tris-HCl, pH  7.5, 0.05  M  NaC1, and 
0.05% wt/vol deoxyeollate. 
Animals.  4-8-mo-old mice were  used.  DBA/2J,  DBA/IJ,  C57B1/10,  AKR/J  male and 
female mice were purchased from Jackson Laboratory, Bar Harbor, Maine. C3H.OH, C3H.OL, 
and C3H.WSlp, both sexes, were kindly supplied by Dr. D. C. Shreffier, Washington University, 
St. Louis, Mo., and subsequently bred in our animal facilities.  MP males were donated by Dr. 
G. Biozzi, Fondation Curie, Paris, France. Mice were bled from the axillary vein and artery 
into tubes containing Na3H EDTA to a final concentration of 0.01 M, or allowed to clot for 10 
rain at  room temperature and  1 h  in the ice.  Immediately after centrifugation, 0.005  M  e- 
aminocaproic acid and 0.004 M DFP were added to both serum and plasma, which were used 
on the same day. 
Antisera.  Rabbit anti-mouse Ss  donated by Dr.  H.  Passmore,  Rutgers  University, New 
Brunswick, N. J.  (12) was used. This antiserum reacted against a single component of mouse 
serum by crossed immunoelectrophoresis. Mouse antisera to mouse Sip and C5 were obtained 
as previously described (12,  13). Goat anti-human C4, strongly cross-reactive with mouse Ss 
and  weakly  cross-reactive  with  mouse  Slp,  was  purchased  from  Meloy  Laboratories  Inc., 
Springfield, Va. A rabbit antiserum to human C3, strongly cross-reactive with mouse C3, was 
prepared by injecting 100/~g of pure human C3 incorporated in complete Freund's adjuvant, 
into rabbits. A  rabbit antiserum to mouse C4-bp was prepared as described  (10). The IgG 
fractions of normal mouse serum or mouse antiserum to mouse C5 and Sip were prepared by 
passage of the sera through a  Sephadex G-200 column. The second protein peak containing 
IgG was  pooled  and  an equal  volume of saturated  ammonium sulphate was  added.  The 
precipitate was dissolved in PBS and further purified by Pevikon block electrophoresis (Mercer 
Consolidated Corp.,  Yonkers,  N.  Y.)  (14). Anti-C5 and  anti-Slp containing fractions were 
detected by rocket immunoelectrophoresis,  pooled, and dialyzed against veronal-buffered  saline. 
The IgG fractions of goat anti-human C4, and of rabbit anti-human C3, cross-reactive with 
mouse C3, were obtained by fractionation of whole antisera in DEAE-cellulose columns. 
Immunoprecipitation of radiolabeled Ss  and  Slp:  fractions containing Ss  and  Sip  were 
radiolabeled according to a modification of a previously described method (15): 25 btl of 0.8 M 
Tris-HCl buffer,  pH  7.5, were  added  to  an aqueous solution of 2  mC 12sI, New  England 
Nuclear,  Boston,  Mass.,  followed by  50  /zl  of the  Ss/Slp  containing sample  and  25  /zl  of 
chloramine T  (0.5 mg/ml). The mixture was incubated for 2 min at room temperature; 25/xl 
of sodium metabisulfite (0.5 mg/ml) and 0.5  ml PBS were added to stop the reaction. The 
labeled material was dialyzed against PBS for 24 h and mixed with 0.1 ml of 10 mg/ml BSA. 
Immunoprecipitation was  performed  as  follows:  ~107  cpm  of the  radiolabeled  samples 
containing  Ss and Sip were treated with the IgG fractions of the following antisera: mouse anti- 
mouse Slp, rabbit anti-mouse Ss, or goat anti-human C4. As controls, samples were treated 
with IgG fractions of normal rabbit serum, of rabbit anti-human C3, or normal mouse serum. 
The samples were incubated 2 min in the ice and immune complexes removed by addition of 
100/~1 of a 50% vol/vol Staphylococcus aureus suspension in PBS-EDTA (16) followed by 2 min 
incubation in the ice, with mixing every 30 s. The tubes were centrifuged at 2,000 g for  15 min 
and the pellets washed 5 times with 1.5 ml DOC buffer. The specific radioactivity bound to the 
bacteria was calculated, and the bound complexes were eluted by incubation  at 90°C for 3 min 
with Tris-HCl buffer, 0.08 M, pH 6.8, containing 2% SDS, 6 M urea, and 10% glycerol.  After 
centrifugation, the supernates were counted and specific recoveries calculated. The eluates were 
subjected to SDS-polyacrylamide gel electrophoresis (PAGE) slab electrophoresis under reduc- 
ing and nonreducing  conditions. The gels were stained, dried, and radioautographed for 24-48 
h at -70°C, using Kodak X-omat R film (Eastman Kodak, Rochester, N. Y.). 
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formed as previously described (17,  18), using 5  X  5 cm glass plates. The  levels of antigen 
measured  by  RIE were calculated by comparing the  height of the peaks generated by  the 
samples with that of serially diluted standards which were included in each plate. 
Polyacrylamide Gel Electrophoresis.  SDS-PAGE was performed as previously described (19). In 
all cases, a  3%  stacking gel and  6%  and  7.5% running gels were  used  for nonreducing  and 
reducing conditions, respectively. Approximate molecular weight determinations under reduc- 
ing conditions were calculated using the following markers as standards: yeast alcohol dehy- 
drogenase  (41,000),  beef liver catalase  (60,000),  BSA  (68,000),  rabbit  muscle phosphorilase 
(94,000)  and E. coli ~-galactosidase (130,000).  When nonreducing conditions were necessary, 
three  molecular weight  markers were  used,  catalase, albumin,  and  ferritin  (half U:220,000 
dahons). 
C4  hemolytic titration.  Sheep  or  ox  erythrocytes were  coated  with  anti-sheep  or  anti-ox 
hemolysin made in rabbits (EA). EAC1 cells were prepared by mixing EA in DGVB ++ with an 
equal volume of partially purified guinea pig C1, diluted to provide 250 effective molecules/ 
cell. Effective molecular titrations of mouse C4 either in  mouse serum,  plasma, or pools of 
fractions  obtained  from  Sephadex  G-200  columns  were  performed  by  incubating  0.5  ml 
EACi, 1 X  10S/ml, with an equal volume of serial dilutions of the material to be tested. After 
incubation for  15 min at 30°C  the reaction was brought  to completion by the addition of a 
1:100 dilution of C4-deficient guinea pig complement, to which oxydized human C2 had been 
added to overcome species incompatibility between mouse C4 and guinea pig C2. After 60 min 
at 37°C, the hemoglobin released was measured in a  spectrophotometer at E/415 nm. Titers 
were calculated by plotting serum dilutions vs. y/1 -  y (y --- % lysis/100), and determining the 
dilution giving y/1 -  y  =  1. 
C1  treatment of Ss  and Slp.  10  /~1  of purified  C1  (1.4  mg/ml  in  DGVB++),  prepared  as 
described in reference 20, were added to 100 btl of the Ss/Slp-containing sample. A control tube 
received an equal volume of buffer. Both tubes were incubated  1 h at 37°C. The effect of Ci 
on  Ss  or  Sip  was  assessed  functionally,  in  CIE  and  by  SDS-PAGE  under  reducing  and 
nonreducing conditions. 
Statistical Analysis.  The effect on C4 hemolytic activity of removal of Ss or Slp antigens was 
assessed  by  determining the  correlation coefficient  (r)  between  two  variables  (depletion of 
antigen vs. decrease in hemolytic activity) after regression analysis by the least squares method. 
Results 
Pattern  of Elution from Sephadex  G-200 Columns  of Ss and Slp Antigens and C4 Hemolytic 
Activity.  Fig.  1  shows  the  pattern  of elution  of the  Ss  and  Sip  antigens  and  C4 
hemolytic activity. In  plasma  (Fig.  1 A)  the bulk  of Ss antigen  and  C4  hemolytic 
activity (shaded area) appear in the ascending portion of the second protein peak. In 
serum,  most of the hemolytic activity is lost and the Ss antigen is now found  in  the 
first peak, superimposed with C4-bp. Slp elutes in the second peak in both serum and 
plasma. 
Those  plasma fractions which  contained  C4  hemolytic activity were  pooled  and 
used  as  a  source  of Ss  and  Sip  in  most  of the  experiments  described.  To  remove 
contaminating IgG, the pool was treated with  10% vol/vol S. aureus for 1 h  in ice. The 
pretreatment  did not affect either the C4 hemolytic activity or the amount  of Ss or 
Sip antigens. 
Relationship between  the  Ss Protein  and C4 Hemolytic Activity.  To  determine whether 
there was a relationship between the Ss or Sip proteins and C4 hemolytic activity, the 
Ss/Slp positive pooled fractions from the chromatographic separation of plasma from 
male and female mice were treated with IgG preparations from mouse anti-mouse Slp 
and  goat  anti-human  C4  which  cross-reacted  with  mouse  Ss.  This  cross-reactive 
antiserum  (rather  than  rabbit  anti-Ss)  was  used  because  most  antisera  to  Ss  are 
polyspecific, and  after the necessary absorptions, they may contain soluble immune 
complexes. However, the depletion of Ss antigen by the cross-reactive antiserum was ARTURO  FERREIRA,  VICTOR  NUSSENZWEIG,  AND  IRMA  GIGLI  1189 
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FIG.  1.  Sephadex O-200 gel filtration of pooled EDTA-plasma (A) or serum (B) from adult DBA/ 
2J  (H-2d,  SsH-SIp positive) male mice. Buffer VBS-, pH  7.4,  7.4 mS at 0°C, containing 0.002 M 
NHa EDTA and 0.005 M ~-amino-caproic acid. Relative concentrations of C4-bp, Ss, and Sip were 
determined by RIE. (24 hemolytic activity is shown in the shaded area. 
C4-bp was found in  the first peak  in serum and plasma.  Sip and C4 hemolytic activity were 
found in the ascending limb of the second peak. After fractionation serum contained only 7-8% of 
the C4 hemolytic activity of plasma. In plasma, the bulk of the Ss antigen was found in the second 
protein peak, but in serum, it was found in the first peak together with C4-bp. 
Similar results were obtained with serum and plasma from C3H.WSIp and MP males. 
evaluated by RIE using monospecific rabbit anti-Ss. Control samples received either 
IgG from rabbit anti-human C3, which cross-reacted with mouse C3, or from mouse 
anti-mouse C5. After removal of the immune complexes (by treatment with S. aureus), 
Ss or Sip levels, and C4 hemolytic activity were measured  in  the supernates.  Fig.  2 
shows that specific removal of Ss, correlated almost perfectly (r  --  0.99,  P  <  0.001), 
with the decrease in C4 hemolytic activity. Fig. 3 shows the results of hemolytic assays 
in Sip-depleted fractions. In contrast with the previous results, we found no correlation 
between Sip levels and C4 hemolytic activity. Removal of unrelated antigens by anti- 
C3  (Fig.  2)  and  anti-C5  (not  shown)  did  not  affect  the  levels of Ss  antigen  or C4 
hemolytic activity. 
To further demonstrate the correlation between Ss levels and C4 hemolytic activity, 
these  two  parameters  were  measured  in  plasma  and  serum  from  phenotypically 
negative Slp mice from different strains. As shown in Fig. 4, the correlation coefficient 
(r)  between these two variables was 0.94 (P <  0.001). When sera or plasma from Sip- 
positive strains were included, r -- 0.74, 0.01  >  P>  0.001. This decrease in significance 
is  to  be  expected,  because  Sip  does  not  have  hemolytic  activity  although  it  is 
recognized by antisera to Ss. 
Structure of Ss  and  Slp  and Susceptibih'ty  to  the  Enzymatic  Activity  of CL  Next,  we 
evaluated the effect of C 1 on the function of mouse C4. Duplicate samples of the pool 1 190  DIFFERENCES  BETWEEN  H-2  CONTROLLED  Ss  AND  Sip  PROTEINS 
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FIO.  2.  Correlation between Ss antigen and C4 hemolytic activity. Tubes from the ascending limb 
of the second protein peak of Sephadex chromatography (Fig.  1 A) were pooled and 100-#l  samples 
were incubated with IgG anti-human C4, which is cross-reactive with Ss (A and C), and IgG anti- 
human  C3,  which  is  cross-reactive  with  mouse C3  (B  and  D).  After  removal  of the  immune 
complexes by treatment with S. aureus, the levels of Ss and C3 antigens were measured by RIE and 
the degree of C4 hemolytic activity determined. 
The correlation coefficient between the levels of Ss antigen and C4 hemolytic activity is 0.99 for 
males (A) and 0.98 for females (C), for seven and four degrees of freedom, respectively (P <  0.001 
in both cases). 
Removal of an unrelated antigen (B and D) did not affect the levels of Ss nor the C4 hemolytic 
activity. Similar results were obtained with DBA/2J and C3H.WSIp male mice. ARTURO  FERREIRA,  VICTOR  NUSSENZWEIG,  AND  IRMA  GIGLI  1 191 
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FzG.  3.  Lack of correlation between the SIp antigen and G4 hemolytic activity. The source of Ss/ 
Slp positive fractions was described in the legend of Fig. 2.  100-~1 samples were incubated with IgG 
anti-Sip. After removal of the immune complexes with S.  aureus,  the levels of Ss and Sip antigens 
were determined by RIE and C4 activity measured.  100% of the Sip antigen could be removed 
without affecting the G4 hemolytic activity. 
from the G-200 column, containing both proteins, and  which had  a  C4  hemolytic 
titer of 3,000 U/ml, were treated with purified C1 or with buffer. After C1 treatment, 
C4 hemolytic activity was totally abolished. 
To  determine  the  effect  of C1  on  the  structure  of Ss  and  Sip,  samples  were 
radiolabeled and immunoprecipitated with either anti-human G4, which cross-reacts 
strongly with  Ss and  weakly with  Slp  (see below), or with  anti-Sip.  The immune- 
complexes were bound to S.  aureus.  After repeated washings, the radiolabeled Ss and/ 
or Sip molecules, which remained bound to the bacteria, were eluted and analyzed 
by slab SDS-PAGE and radioautography. 
Under nonreducing conditions (Fig. 5) native Ss and Sip have a mol wt of 205,000 
daltons  (tracks  1 and 3). Cl-treated Ss and Sip molecules are shown in tracks 2 and 
4.  It is clear that C1 cleaved the Ss molecules, resulting in the loss of a  fragment of 
7,000-8,000 daltons, although it had no effect on Sip. Tracks 5 and 6 are controls for 
nonspecific precipitation with normal rabbit and normal mouse serum. 
Fig. 6 shows the polypeptide chains of Ss and Sip after reduction and alkylation. 
Native Sip has  three chains,  with  apparent  mol wt  of 105,000,  74,500,  and  32,000 
daltons, respectively (track 3). The calculated sum of the mol wt of these three chains 
is  211,500  in  agreement  with  that  observed for unreduced  Slp  (Fig.  5).  Native Ss, 
immunoprecipitated by goat anti-human C4, is shown in track 2. Similarly to Sip, it 
has three chains but  their tool wt are different: 98,000,  77,000, and  34,000 daltons. 
This antiserum to C4 appears not to have recognized the Sip molecules. In reality, the 
antiserum to human C4 does cross-react with Sip, and the immunocomplexes bind to 
S.  aureus.  However, after multiple  washings,  the  Sip  molecules dissociate  from  the 1192  DIFFERENCES BETWEEN  H-2  CONTROLLED  Ss  AND Sip  PROTEINS 
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FIG. 4.  Correlation between the levels of Ss and C4 hemolytic activity in plasma from different 
strains of mice. Bleedings were done into plastic tubes containing 0.005 M e-aminocaproic acid and 
0.010 M Naris EDTA. After separating the plasma, DFP was added to a concentration of 0.004 M. 
C4 hemolytic activity and levels of Ss were determined in pools of plasma from three mice per 
strain. 
The closed circles represent  plasma from mice which do not contain SIp antigen. The four closed 
circles near the origin are from two Ss-low strains  (AKR/J and C3H.OL), males and females, The 
other five closed circles represent,  in  the order of increasing hemolytic activity, the plasma  from 
C57B1/10Sn  males,  C3H.OH  females,  and  MP females. The open circles represent  plasma from 
Sip-positive  mice: C3H.WSIp, males and females, C3H.OH males, and MP males. The correlation 
coefficient between the levels of Ss and C4 hemolytic activity in the Sip negative samples was 0.94 
(P <  0.001 for seven degrees of freedom). 
When the four Sip positive samples  were included, the correlation coefficient  decreased  to 0.74 
(0.01 >  P > 0.001, for 11 degrees of freedom). 
Similar levels of C4 hemolytic activity were obtained in serum samples  from the same animals, 
provided ~-aminocaproic  acid, diisopropyl-fluorophosphate and NaHaEDTA were added immedi- 
ately after clotting. 
antibodies  although  the Ss molecules remain  firmly bound. 
The effect of C1  on Ss and  Sip is also shown  in  Fig.  7,  tracks  2  and  6.  No changes 
in  the  a-,/3-,  and  y-chains  of Sip  were  detected.  In  contrast,  the  a-chain  of the  Ss 
protein was cleaved, and a  90,000-tool wt fragment  (a') was observed. The a-,/3- and 
3,-chains  of  both  Ss  and  Sip  molecules  which  were  immunoprecipitated  with  an 
antiserum to Ss, are shown in tracks 3 and 4. Antisera to Ss do not distinguish between 
Ss and  Sip molecules, thus  six distinct  polypeptide  chains  are seen.  Again,  it  is clear 
that  only the a-chain of Ss is cleaved by C1  (track 4). 
Finally, we asked whether genotypically Sip-negative mice have Sip-like molecules 
in their serum. Until recently, the presence or absence of Slp could only be ascertained ARTURO  FERREIRA,  VICTOR  NUSSENZWEIG,  AND  IRMA  GIGLI  1193 
Fro.  5.  Effect of C1 on Ss and Sip molecules as detected by SDS-PAGE. Tubes from the ascending 
limb of the second protein peak of Sephadex G-200 chromatography (Fig.  1 A)  were pooled.  A 
sample was radiolabeled with lznI and  100 #1 incubated with  14 #g (10 #1) of purified human C1. 
Control was incubated with an equal volume of buffer. After incubation, each sample was divided 
in four aliquots and treated with IgG obtained from anti-human C4  (cross-reactive  with Ss), anti 
SIp,  normal rabbit serum, and normal mouse serum. Immune complexes were bound to S.  aureus, 
eluted with SDS-urea, and subjected to SDS-PAGE under nonreducing conditions. 
Tracks  1-6 show,  respectively:  native Ss,  Ss  treated with C1,  Sip,  Sip  treated  with CI,  and 
controls with normal mouse serum and normal rabbit serum. It is clear that CI splits Ss but not Sip. 
Flo.  6.  Structure of Ss and Sip molecules as determined in SDS-PAGE. Experimental conditions 
were as described in Fig.  5, except that C I treatment was omitted and a  7% SDS-PAGE was run 
under reducing conditions. Tracks  1 and 4 show the results of controls with normal rabbit serum 
and normal mouse serum, respectively.  Tracks 2 and 3 show the results of immunoprecipitation 
with IgG anti-human C4 and anti-Sip, respectively.  The ¢t-, fl-,  and y-chains of Ss and Sip have 
different molecular weights. It also appears that the antiserum to human C4 did not immunopre- 
cipitate Sip molecules. 
by  reactivity  with  the  alloantiserum.  No  alloantiserum  has  been  prepared  which 
recognizes  the  allelic  product  which  might  be  present  in  Sip-negative  mice.  The 
present results show an additional  way of identifying Sip-molecules,  because they are 
structurally different from Ss molecules. We attempted  to immunoprecipitate  Slp-like 
molecules  from  serum  of C57  B1/10  and  A.CA  mice.  (Ss-high,  SIp  negative)  with 1194  DIFFERENCES BETWEEN  H-2  CONTROLLED  Ss AND  Sip PROTEINS 
Fxc. 7.  Assessment of C1 effect on the polypeptide chains of Ss and Sip. Experimental  conditions 
were as in Fig. 5. A 7% SDS-PAGE was run under reducing conditions. Immunoprecipitation was 
performed with antisera  to human C4, Sip, and Ss. Anti-human C4 (track 3) did not precipitate 
Sip. Anti-Ss (track 5) recognized Ss and Slp. Only the specific bands, a, fl, and ),, are indicated. C l 
treatment did not affect the Sip chains, as shown in tracks 2 and 6, but cleaved the ~t-chain of Ss 
with loss of an 8,000-dahon fragment  (tracks 4 and 6). Track 6 also shows that, out of six specific 
bands,  the  only  affected  by CI  treatment  was  Ss-a. Track  5  clearly  shows the  differences in 
molecular weight between the a-, fl- and -/- chains from Ss and Sip. The same results were obtained 
with  two other SsH-SIp positive strains  (C3H.WSIp  and C3H.OH).  When anti-Ss  was used to 
immunoprecipitate  Sip-negative strain (C57 BI/10 and A.CA), only three specific bands were seen, 
and their apparent molecular weights coincided with the bands precipitated with anti-human C4. 
antiserum  to  Ss.  By  SDS-PAGE,  only  three  bands  were  seen,  and  their  molecular 
weight coincided precisely with those obtained with antiserum to human  C4. There- 
fore, Sip appears indeed to be absent in these mice, or it cannot be separated from Ss 
molecules by SDS-PAGE. 
Discussion 
The results presented in this paper deal with structural and  functional differences 
between the Ss and Sip proteins and clarify a  number of contradictory observations 
as  to  the  relationship  between  these  proteins  and  the  hemolytic  activity of mouse 
complement. 
The different elution patterns of the Ss and Slp proteins and C4 hemolytic activity 
obtained  when  mouse  plasma  and  serum  are  filtered  through  a  Sephadex  G-200 
column  are shown  in Fig.  1.  In EDTA-plasma, most of the Ss antigen was found in 
the  ascending  limb  of the  second  protein  peak,  although  in  serum  it  was  present 
primarily in the first peak, associated with C4-bp.  (10).  In contrast, Sip eluted in the 
second  protein  peak,  whether  it  was  fractionated  with  plasma  or  serum.  Identical 
results  were  obtained  using  plasma  and  serum  from  several  Ss  high,  Slp  positive 
strains of mice  (C3H.WSIp, C3H.OH,  DBA/2J,  MP).  In contrast with the observa- 
tions of Goldman et al.  (21), C4 hemolytic activity was invariably found only in the 
ascending limb of the second protein peak. No hemolytic activity was associated with 
the Ss/C4-bp complexes (10)  present in the first peak. 
C4  activity in serum  represented only  10%  of that  found  in plasma.  (Fig.  1).  It is 
very  likely that  this  decrease  in  C4  titers  reflects  the  activation  of C1  during  the ARTURO FERREIRA, VICTOR NUSSENZWEIG, AND IRMA GIGLI  1195 
fractionation of serum, as reported by Sj6holm and  Laurell  (22)  rather than inacti- 
vation  of C4  by  enzymes  generated  during  clotting.  Indeed,  measurement  of C4 
hemolytic activity in whole serum  and  plasma  yielded identical C4  titers provided 
~-aminocaproic acid and DFP were added to the serum after separation of the clot. 
Direct  evidence that  Ss  protein mediates C4  hemolytic activity was  obtained in 
experiments in which different proportions of Ss  antigen were specifically removed 
from plasma  fractions.  C4  activity was  measured  in  these  fractions and  compared 
with the levels of remaining Ss protein (Fig. 2). The two variables correlated with a 
high degree of significance (r --  0.99, P <  0.001). In contrast, no significant decrease 
in  C4  hemolytic activity was  observed in samples  in  which  up  to  100% of the  Slp 
antigen was removed (Fig. 3). 
Next, we compared Ss levels and C4 hemolytic activity in plasma  and/or serum 
from phenotypically Sip negative mice (Fig. 4). A  highly significant correlation was 
obtained (P <  0.001). This degree of significance decreased if serum or plasma from 
Sip  positive  mice  were  included.  This  was  expected,  because  Sip  does  not  have 
hemolytic activity but is recognized by the antiserum to Ss. 
These  results  explain  some of the  previously reported  discrepancies  between  Ss 
levels and C4 hemolytic activity (21), because the contribution of Sip to the measur- 
able Ss antigenic levels were not taken into consideration. Additional difficulties are 
that  unless  precautions  are  taken  to prevent activation  of serum  proteases,  the  Ss 
protein is rapidly cleaved during fractionation and binds to C4-bp forming complexes 
with  high  molecular  weight  (10)  which  are  hemolytically  inactive.  Finally,  most 
techniques used for detection of mouse C4 do not provide the optimal conditions for 
its measurement. The use of sensitized ox erythrocytes and C4 deficient guinea pig 
serum to which oxidized human C2 (23)  was added, to overcome species incompati- 
bilities  (24)  in  the  formation of the  C42  enzyme,  increased  the  sensitivity  of C4 
titration in mouse plasma or serum. 
Because  the  Ss  protein  expresses  the  functional  activity  of  C4,  it  should  be 
susceptible to the enzymatic effect of C1. Indeed, treatment with C1 cleaved Ss with 
loss of a  7,000-8,000-dalton fragment although Sip was not altered in its molecular 
size.  (Figs.  5  and  7).  By  CIE,  Cl-treated  Ss  showed  a  faster  moving component 
consistent with conversion of C4 to C4b (not shown). In addition, cleavage of the Ss 
protein was associated with complete loss of C4 hemolytic activity. 
Ss  and  Sip differ also structurally.  As shown  in  Fig.  6  (track 2)  Ss,  the same as 
human C4, consists of three covalently linked polypeptide chains with apparent mol 
wt of 98,000, 77,000, and 34,000 daltons. The Slp protein displays the same molecular 
weight as Ss when subjected to SDS-PAGE in the absence of reducing agents (Fig. 5) 
and, upon reduction, three specific bands a, fl and y are also seen. However, their mol 
wt,  105,000, 74,000, and 32,000 daltons (Fig. 6, track 3) differ respectively from those 
of Ss (track 2). Previous studies on the structure of the Sip protein have indicated that 
it consisted of three chains covalently linked, differing somewhat in the mol wt of a- 
and  y-chains  (7).  Our  results  confirm  these  observations  and  show,  in  addition, 
differences in the fl-chain. 
Based on the functional and structural data summarized in Table I, we conclude 
that the Ss protein (but not Slp) represents the fourth component of complement in 
mouse serum. Recently Carrol and Capra (25)  have partially isolated Ss from mouse 
ascitis fluid. Although the ascitis fluid contained functional C4 there was no correla- 
tion between the protein concentration and the functional activity, as compared to 1196  DIFFERENCES  BETWEEN  H-2  CONTROLLED  Ss  AND  Sip  PROTEINS 
TABLE  I 
Differences between Ss and Slp Molecules 
Property  Ss  Sip 
Recognition  by  anti-  Yes  Poor 
human C4 
Binding to C4-bp  Yes  No 
Activable by C1  Yes  No 
C4 hemolytic activity  Yes  No 
Molecular  weight  of 
chains 
a  98,000  105,000 
fl  77,000  74,500 
y  34,000  32,000 
plasma.  When  the  partially  purified  Ss was  analyzed by  SDS-PAGE,  three  major 
bands  and  one minor band  of estimated  mol wt  of 190,000,  160,000,  106,000  and 
90,000 were seen. These molecular weights are in disagreement with ours for the Ss 
protein  and  those  reported  for  native  human  C4.  The  190,000  mol  wt  material 
probably contains primarily C4b, and the  160,000 may represent the C4c fragment 
generated by the action of C4-bp and C3b inactivator on Ss. 2 In addition, Carrol and 
Capra showed that  treatment of mouse plasma with F(ab')2 fragments of immuno- 
globulins from an antiserum to Ss abrogated the C4 hemolytic titer. 
Summary 
Based on functional and structural data, it is concluded that the Ss protein in the 
mouse expresses the activity of the fourth component of complement. Removal of the 
Ss, but not of Sip, antigen correlates with a  high degree of significance (P <  0.001) 
with  decrease  of C4  hemolytic activity.  In  phenotypically  Sip  negative  mice  the 
plasma/serum levels of Ss correlate with the C4 activity (P <  0.001). 
Structurally, Ss is a  209,000-mol wt protein, consisting of three covalently linked 
polypeptide chains (a, fl, y). Treatment of Ss with C1 cleaves a  7,000-8,000-mol wt 
fragment  from  the  a-chain.  Slp  is  also  a  three chain  covalently linked  protein  of 
209,000 daltons, however its three chains differ in size from those of the Ss protein. 
Slp does not express hemolytic activity and its a-chain is not cleaved by Ci. 
We thank Monique Sauter and Michael Kushner for their excellent technical assistance. 
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